• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状系统性硬化症患者食管高分辨率阻抗测压改变:患病率、与疾病特征的关联和预后价值。

Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value.

机构信息

Rheumatology Section, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", c/o II Policlinico, via Pansini 5, 80131, Naples, Italy.

Division of General, Mini-Invasive and Bariatric Surgery, Department of Surgery, University of Campania "Luigi Vanvitelli", II Policlinico, Via Pansini 5, 80131, Naples, Italy.

出版信息

Clin Rheumatol. 2018 May;37(5):1239-1247. doi: 10.1007/s10067-018-4026-1. Epub 2018 Feb 13.

DOI:10.1007/s10067-018-4026-1
PMID:29442260
Abstract

This study aims to investigate pre-clinical esophageal involvement in systemic sclerosis (SSc) by high-resolution impedance manometry (HRiM), its associations with disease features including lung involvement, and its predictivity of esophageal symptoms overtime. Charts of 45 asymptomatic (no heartburn/regurgitation/dysphagia) SSc patients (96% females; mean age 46 years) with at least one follow-up (FU) visit and complete clinical, serological, functional, and radiological assessment, including high-resolution computed tomography (HRCT) of the chest and lung function tests, that had undergone esophageal HRiM were retrospectively evaluated. Esophagogastric junction-contractile integral (EGJ-CI) and esophageal body motility, as evaluated by mean distal contractile integral (DCI), were assessed. SSc patients had a normal esophageal motility in 7/45 cases, a defective EGJ-CI in 28, an ineffective esophageal motility (IEM) in 17, and aperistalsis in 12. Defective EGJ-CI was associated with IEM/aperistalsis in 20 cases, while 9 patients had isolated IEM. Defective EGJ-CI and/or IEM/aperistalsis were associated with a diffusing lung capacity for CO < 80% of predicted value (all p < 0.05), while defective EGJ-CI was also associated with interstitial lung disease on HRCT (p = 0.03). Prevalence of any HRiM abnormality was higher in anti-centromere antibody negative patients (all p < 0.05). IEM/aperistalsis independently increased the risk of esophageal symptoms by 2.3-fold (95% CI 1.1-5.7) and was associated with their higher cumulative incidence with respect to patients with other HRiM patterns at FU (χ = 4.63; p = 0.03). SSc patients asymptomatic for esophageal involvement can have HRiM abnormalities in up to 84% of cases. A baseline-impaired motility is a risk factor for symptomatic esophageal disease.

摘要

本研究旨在通过高分辨率阻抗测压(HRiM)研究系统性硬化症(SSc)的食管前临床受累情况,及其与包括肺受累在内的疾病特征的关联,并预测其随时间发展的食管症状。对 45 例无症状(无心酸/反流/吞咽困难)SSc 患者(96%为女性;平均年龄 46 岁)的图表进行了回顾性评估,这些患者至少有一次随访(FU)就诊且完成了完整的临床、血清学、功能和影像学评估,包括胸部高分辨率计算机断层扫描(HRCT)和肺功能检查,均进行了食管 HRiM。评估了食管胃交界处收缩积分(EGJ-CI)和食管体运动,通过平均远端收缩积分(DCI)进行评估。45 例 SSc 患者中有 7 例食管运动正常,28 例 EGJ-CI 受损,17 例无效食管动力(IEM),12 例蠕动不良。20 例 EGJ-CI 受损与 IEM/蠕动不良有关,9 例患者为孤立性 IEM。EGJ-CI 受损和/或 IEM/蠕动不良与弥散性肺活量低于预测值的 80%(所有 p<0.05)有关,而 EGJ-CI 受损也与 HRCT 上的间质性肺病有关(p=0.03)。抗着丝粒抗体阴性患者的任何 HRiM 异常的患病率均较高(所有 p<0.05)。IEM/蠕动不良独立使食管症状的风险增加 2.3 倍(95%CI 1.1-5.7),并且在 FU 时与其他 HRiM 模式患者相比,其食管症状的累积发生率更高(χ2=4.63;p=0.03)。无症状食管受累的 SSc 患者在高达 84%的情况下可能存在 HRiM 异常。基线运动障碍是食管疾病症状的危险因素。

相似文献

1
Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value.无症状系统性硬化症患者食管高分辨率阻抗测压改变:患病率、与疾病特征的关联和预后价值。
Clin Rheumatol. 2018 May;37(5):1239-1247. doi: 10.1007/s10067-018-4026-1. Epub 2018 Feb 13.
2
The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.系统性硬化症疾病表现与食管高分辨率测压参数之间的关联。
Neurogastroenterol Motil. 2016 Aug;28(8):1157-65. doi: 10.1111/nmo.12813. Epub 2016 Feb 27.
3
Esophageal manometry in systemic sclerosis: screening procedure or confined to symptomatic patients?系统性硬化症中的食管测压:筛查手段还是仅用于有症状的患者?
Rheumatol Int. 1997;17(2):61-6. doi: 10.1007/s002960050010.
4
Distal contractile to impedance integral ratio assist the diagnosis of pediatric ineffective esophageal motility disorder.远端收缩-阻抗积分比值有助于小儿无效食管动力障碍的诊断。
Pediatr Res. 2018 Dec;84(6):849-853. doi: 10.1038/s41390-018-0197-3. Epub 2018 Oct 1.
5
Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification.根据芝加哥分类法,系统性硬化症患者高分辨率食管测压下食管动力障碍的频谱。
Dis Esophagus. 2017 Dec 1;30(12):1-6. doi: 10.1093/dote/dox067.
6
Esophagogastric junction and esophageal body contraction metrics on high-resolution manometry predict esophageal acid burden.高分辨率测压法中食管胃结合部和食管体收缩指标预测食管酸负荷。
Neurogastroenterol Motil. 2018 May;30(5):e13267. doi: 10.1111/nmo.13267. Epub 2017 Dec 21.
7
Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease.胃食管反流病行胃底折叠术后无效食管动力表型
Neurogastroenterol Motil. 2016 Feb;28(2):292-8. doi: 10.1111/nmo.12728. Epub 2015 Nov 17.
8
Characteristics of Consecutive Esophageal Motility Diagnoses After a Decade of Change.十年变迁后连续食管动力诊断的特征
J Clin Gastroenterol. 2016 Apr;50(4):301-6. doi: 10.1097/MCG.0000000000000402.
9
High-resolution impedance manometry parameters enhance the esophageal motility evaluation in non-obstructive dysphagia patients without a major Chicago Classification motility disorder.高分辨率阻抗测压参数可增强对无严重芝加哥分类运动障碍的非梗阻性吞咽困难患者的食管动力评估。
Neurogastroenterol Motil. 2017 Mar;29(3). doi: 10.1111/nmo.12941. Epub 2016 Sep 20.
10
Increased inspiratory esophagogastric junction pressure in systemic sclerosis: an add-on to antireflux barrier.系统性硬化症中吸气时食管胃交界压力增加:抗反流屏障的补充因素
World J Gastroenterol. 2015 Feb 21;21(7):2067-72. doi: 10.3748/wjg.v21.i7.2067.

引用本文的文献

1
Esophageal dysmotility in systemic sclerosis: Relationship with extra-gastrointestinal manifestations and complementary utility of thoracic imaging.系统性硬化症中的食管动力障碍:与胃肠道外表现的关系及胸部影像学的辅助作用
J Scleroderma Relat Disord. 2025 Aug 8:23971983251362586. doi: 10.1177/23971983251362586.
2
The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes.胃食管反流病及其治疗对间质性肺病结局的影响。
Arthritis Res Ther. 2024 Jun 25;26(1):124. doi: 10.1186/s13075-024-03355-0.
3
Diffuse Gastrointestinal Motor Compromise in Patients with Scleroderma: Utility of Minimally Invasive Techniques.

本文引用的文献

1
High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis.高分辨率测压法与加利福尼亚大学洛杉矶分校硬皮病临床试验联盟 GIT 2.0 在系统性硬化症中的比较。
Semin Arthritis Rheum. 2017 Dec;47(3):403-408. doi: 10.1016/j.semarthrit.2017.05.005. Epub 2017 May 19.
2
Esophageal Motor Abnormalities in Patients With Scleroderma: Heterogeneity, Risk Factors, and Effects on Quality of Life.硬皮病患者的食管运动异常:异质性、危险因素和对生活质量的影响。
Clin Gastroenterol Hepatol. 2017 Feb;15(2):207-213.e1. doi: 10.1016/j.cgh.2016.08.034. Epub 2016 Sep 6.
3
硬皮病患者的弥漫性胃肠道动力障碍:微创技术的应用。
Dig Dis Sci. 2024 Jan;69(1):191-199. doi: 10.1007/s10620-023-08151-5. Epub 2023 Nov 20.
4
Clinical Risk Factors for Dysphagia and Esophageal Dysmotility in Systemic Sclerosis.系统性硬化症吞咽困难和食管动力障碍的临床风险因素
J Clin Med. 2023 May 13;12(10):3448. doi: 10.3390/jcm12103448.
5
Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.系统性硬化症的胃肠道动力障碍:危险因素、病理生理学、诊断与管理
Nat Rev Rheumatol. 2023 Mar;19(3):166-181. doi: 10.1038/s41584-022-00900-6. Epub 2023 Feb 6.
6
Development of a Diagnostic Model Focusing on Esophageal Dysmotility in Patients with Systemic Sclerosis.聚焦系统性硬化症患者食管动力障碍的诊断模型的开发。
Diagnostics (Basel). 2022 Dec 13;12(12):3142. doi: 10.3390/diagnostics12123142.
7
Esophageal Dilatation as a Predictor of Systemic Sclerosis in Patients with Interstitial Lung Disease.食管扩张作为间质性肺疾病患者系统性硬化症的预测指标
Turk Thorac J. 2021 May;22(3):231-236. doi: 10.5152/TurkThoracJ.2021.19162.
8
Esophageal Dysfunction in Systemic Sclerosis: An Update.系统性硬化症中的食管功能障碍:最新进展
Rheumatol Ther. 2021 Dec;8(4):1535-1549. doi: 10.1007/s40744-021-00382-0. Epub 2021 Oct 9.
9
Gastrointestinal manifestations of systemic sclerosis: An updated review.系统性硬化症的胃肠道表现:最新综述
World J Clin Cases. 2021 Aug 6;9(22):6201-6217. doi: 10.12998/wjcc.v9.i22.6201.
10
Esophageal manifestation in patients with scleroderma.硬皮病患者的食管表现
World J Clin Cases. 2021 Jul 16;9(20):5408-5419. doi: 10.12998/wjcc.v9.i20.5408.
The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.
5-羟色胺1A受体激动剂丁螺环酮可改善系统性硬化症患者的食管运动功能和症状:一项为期4周的开放标签试验。
Arthritis Res Ther. 2016 Sep 1;18(1):195. doi: 10.1186/s13075-016-1094-y.
4
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement.食管测压使用的实践指南——GISMAD-SIGE-AIGO医学立场声明
Dig Liver Dis. 2016 Oct;48(10):1124-35. doi: 10.1016/j.dld.2016.06.021. Epub 2016 Jun 27.
5
Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry.系统性硬化症中的食管和直肠受累:高分辨率测压法的系统评估
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):63-69. Epub 2016 May 24.
6
Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis.通过多次快速吞咽测定的蠕动储备丧失是系统性硬化症患者中最常见的食管动力异常。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1502-6. doi: 10.1016/j.cgh.2016.03.039. Epub 2016 Apr 5.
7
The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.系统性硬化症疾病表现与食管高分辨率测压参数之间的关联。
Neurogastroenterol Motil. 2016 Aug;28(8):1157-65. doi: 10.1111/nmo.12813. Epub 2016 Feb 27.
8
High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity.系统性硬化症患者的高分辨率食管测压和24小时阻抗-pH研究:与临床特征、症状及严重程度的关联
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):115-121. Epub 2016 Jan 29.
9
Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value?胃食管交界处收缩功能在胃食管反流病患者临床评估中的作用:真的具有附加价值吗?
Neurogastroenterol Motil. 2015 Oct;27(10):1423-31. doi: 10.1111/nmo.12638. Epub 2015 Jul 30.
10
Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study.5-HT1A 受体激动剂丁螺环酮对系统性硬化症相关食管功能障碍的有益作用:一项初步研究。
United European Gastroenterol J. 2015 Jun;3(3):266-71. doi: 10.1177/2050640614560453.